Existing evidence and cohorts

Workpackage #1

Existing evidence and cohorts

WP1 will gather and organise health information from of a wide range of CVD patients. This will include information on medical tests (diagnostic screenings), the presence of other medical conditions (comorbidities), data from fitness trackers and health apps (wearable data) and other measurable indicators of health in the body (biomarkers)

Meet our team

Uniklinik RWTH Aachen

Dirk Müller – Wieland

Head, Clincial trial Center for Cardiovascular – metabolic Medicine

Novo Nordisk

Katja Zilonova

Senior Research Scientist

Uniklinik RWTH Aachen

Marlo Verket

MSPH – University Hospital RWTH Aachen

Decentriq

Nikolas Molyndris

Product Lead, Healthcare & Life science

Human Technopole

Emanuele Di Angelantonio

Head of Health Data Science Centre

Human Technopole

Gianmauro Cuccuru

Senior data manager

Human Technopole

Giulia Mangiameli

Scientific Project Manager

Uniklinik RWTH Aachen

Paul Balfanz , MD

CARDIATEAM cohort

Queen’s University Belfast

Donna Fitzsimons

Professor of Nursing & Head of School of Nursing & Midwifery

Queen’s University Belfast

Anne McNulty

Research assistant

TNO

Martien Caspers , Ing/MSc

Dept. Microbiology & SystemsBiology (MSB)

University College Dublin

Carel le Roux

University College of Dublin

University College Dublin

Werd Al – Najim, Dr.

University College Dublin

University of Glasgow

Alasdair Henderson , Dr.

University of Glasgow

IMEC

John Morales

Researcher

Get updated

Our related news

7 August, 2025

The CDE-Mapper: iCARE4CVD’s new AI-based tool to standardise health data

iCARE4CVD researchers unveil the CDE-Mapper: an innovative AI tool using Retrieval-Augmented Generation..

Subscribe to our newsletter

Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.

Agree to privacy policy

Funding acknowledgment

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) and Breakthrough T1D under grant agreement No 101112022. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Vaccines Europe, EuropaBio and MedTech Europe.

Disclaimer

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.

Quick Links